Dafna Capital Management LLC / RCUS
Dafna Capital Management LLC’s Arcus Biosciences Inc Position
Does Dafna Capital Management LLC own Arcus Biosciences Inc (RCUS)? Yes — 443.8K shares worth $10M (+2.18% of its 13F portfolio) as of Q1 2026, up from 431.3K shares the prior filed quarter.
Position Value
$10M
Q1 2026
Shares
443.8K
% of Portfolio
+2.18%
Quarters Held
25
currently held
Position History RCUS
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 443.8K | $10M | +2.18% |
| Q4 2025 | 431.3K | $10M | +2.39% |
| Q3 2025 | 627.6K | $9M | +2.11% |
| Q2 2025 | 627.6K | $5M | +1.41% |
| Q1 2025 | 625.1K | $5M | +1.39% |
| Q4 2024 | 254.2K | $4M | +0.96% |
| Q3 2024 | 256.7K | $4M | +0.93% |
| Q2 2024 | 253.2K | $4M | +0.92% |
| Q1 2024 | 231.7K | $4M | +1.00% |
| Q4 2023 | 232.7K | $4M | +1.07% |
| Q3 2023 | 222.7K | $4M | +1.24% |
| Q2 2023 | 225.7K | $5M | +1.25% |
| Q1 2023 | 175.2K | $3M | +0.96% |
| Q4 2022 | 142.2K | $3M | +0.83% |
| Q3 2022 | 178.7K | $5M | +1.26% |
| Q2 2022 | 187.7K | $5M | +1.30% |
| Q1 2022 | 145.2K | $5M | +1.19% |
| Q4 2021 | 117.2K | $5M | +1.19% |
| Q3 2021 | 123.7K | $4M | +1.14% |
| Q2 2021 | 119.7K | $3M | +0.69% |
| Q1 2021 | 57.6K | $2M | +0.38% |
| Q4 2020 | 49.6K | $1M | +0.38% |
| Q3 2020 | 72.1K | $1M | +0.40% |
| Q2 2020 | 72.1K | $2M | +0.51% |
| Q1 2020 | 27.8K | $386,000 | +0.16% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Dafna Capital Management LLC’s full portfolio or all institutional holders of RCUS.